Lifecore Biomedical Avoids U.S. Prosecution Over Alleged Mexico Bribes

null By Richard VanderfordNov. 17, 2023 6:04 pm ET A U.S. company won’t be prosecuted over alleged foreign bribery because it quickly tipped off the U.S. Justice Department. Photo: KEVIN LAMARQUE/REUTERSLifecore Biomedical, a pharmaceutical and medical device manufacturer, won’t face a U.S. bribery prosecution after coming forward to report a former subsidiary’s alleged illegal payments in Mexico.The U.S. Justice Department formally declined to charge Lifecore over bribes that a then newly acquired subsidiary allegedly paid to Mexican government officials, according to a so-called declination letter the Justice Department released Friday. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8Continue reading your article witha WSJ subscriptionSubscribe NowAlready a subscriber? Sign InSponsored OffersTurboTax: Save up to $15 with TurboTax coupon 2023The Motley Fool: Epic Bundle - 3x Expert Stock RecommendationsH&R Block Tax: Get 20% off H&R Blo